Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Pyrithione is an antimicrobial agent used for the treatment of dandruff and seborrheic dermatitis. Pyrithione zinc, or zinc pyrithione or zinc pyridinethione, is a coordination complex consisted of pyrithione ligands chelated to zinc (2+) ions via oxygen and sulfur centers.
- Mechanism
- Curator reviewed · 4 references
Inhibition of fungal growth by pyrithione zinc is linked to increased copper uptake and cellular levels of copper, which is demonstrated by decreased CTR1-lacZ expression and slightly increased CUP1-lacZ expression in affected microorganisms. The coordination complex of pyrithione zinc dissociates, and pyrithione ligand forms a CuPT complex from available extracellular copper in the target organism. Pyrithione acts as an ionophore, interacting nonspecifically with the plasma membrane to shuttle copper into the cell, and facilitates copper transport across intracellular membranes. Copper may be shuttled into the mitochondria. Copper inactivates iron-sulfur (Fe-S) cluster-containing proteins via a mechanism similar to that described for copper-induced growth inhibition in bacteria. Decreased activity of Fe-S proteins leads to inhibition of fungal metabolism and fungal growth. Pyrithione zinc has been shown to slightly increase the levels of zinc.
- Primary indication
- Indicated for the treatment of dandruff and seborrheic dermatitis.Curator reviewed · 4 structured indications
- Formula / weight
- C5H5NOS · 127.16 g/mol (avg)
- First approval
- Canada, 1998
- Also known as
- 2-pyridinethiol 1-oxide · Omadine · Pyridinethiol N-oxide
- Code names
- NSC-290409
- Brand names
- Biokera
Resolves to
FGVVTMRZYROCTH-UHFFFAOYSA-NSMILES[O-][N+]1=C(S)C=CC=C1What you can answer from here — as of September 13, 2026
Which drugs share a target with Pyrithione, and which of those have an active Phase 3 trial?